Patent details
EP3774871 Title: OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
Basic Information
- Publication number:
- EP3774871
- PCT Application Number:
- US2019027019
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197214471
- PCT Publication Number:
- WO2019200122
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
- French Title of Invention:
- NUCLÉASES MODIFIÉES OPTIMISÉES AYANT UNE SPÉCIFICITÉ POUR LE GÈNE DE RÉGION CONSTANTE DU RÉCEPTEUR ALPHA DES LYMPHOCYTES T HUMAIN
- German Title of Invention:
- OPTIMIERTE GENTECHNISCH VERÄNDERTE NUKLEASEN MIT SPEZIFITÄT FÜR DAS ALPHA-KONSTANTREGION-GEN DES MENSCHLICHEN T-ZELL-REZEPTORS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 28/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 04/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 28/06/2023
- Unitary Effect Registration Date:
- 04/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 11/04/2019
- Grant date:
- 28/06/2023
- EP Publication Date:
- 17/02/2021
- PCT Publication Date:
- 17/10/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/06/2023
- EP B1 Publication Date:
- 28/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/04/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/06/2023
- Name:
- Precision BioSciences, Inc.
- Address:
- 302 East Pettigrew Street Dibrell Building, Suite A-100, Durham, NC 27701, United States (US)
Inventor
1
- Name:
- GENSCHEL, Jochen
- Address:
- United States (US)
2
- Name:
- SMITH, James, Jefferson
- Address:
- United States (US)
3
- Name:
- LAPE, Janel
- Address:
- United States (US)
4
- Name:
- LI, Hui
- Address:
- United States (US)
Priority
- Priority Number:
- 201862656809 P
- Priority Date:
- 12/04/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 14/725; A61K 38/46; A61K 35/17; C12N 5/0783; C12N 9/22; A61K 35/76; A61K 39/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202326
- Publication date:
- 28/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|